Opsis Therapeutics Competitors and Similar CompaniesClear all
Opsis Therapeutics's competitors and similar companies include Pharming Group, AM Pharma, Verrica Pharmaceuticals and Entrada Therapeutics.
 Opsis Therapeutics Opsis Therapeutics is a biotechnology company engaged in the development of treatments for retinal diseases. |  Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. |  Verrica Pharmaceuticals Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum. |  Entrada Therapeutics Entrada Therapeutics is a biopharmaceutical company focusing on intracellular biologics. | ||
Founding Date | Founding Date 2016 | Founding Date 1988 | Founding Date 2001 | Founding Date 2013 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Leiden, NL HQ Leiden, NL | Locations Utrecht, NL HQ Utrecht, NL | Locations West Chester, US HQ | Locations Boston, US HQ |
Employees | Employees 5 | Employees 404 | Employees 28 | Employees 176% increase | Employees 18315% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 590.3 m | Valuation ($) N/A | Valuation ($) 71.7 m | Valuation ($) 642.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $35.6m (FY, 2025) | Revenue (est.) $25.4m (FY, 2025) |
Net income | Net income N/A | Net income $2.5m (FY, 2025) | Net income N/A | Net income ($17.9m) (FY, 2025) | Net income ($143.8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 210.3m | Total funding raised N/A | Total funding raised $ 175.6m |
For sources of this data, please see the company profile
View Company Profiles
Pharming Group
HQ
Leiden, NL
Employees
404
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View company
AM Pharma
HQ
Utrecht, NL
Employees
28
AM-Pharma is a biopharmaceutical company that develops medicines for patients.
View companyVerrica Pharmaceuticals
HQ
West Chester, US
Employees
17↑ 6% increase
Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum.
View companyEntrada Therapeutics
HQ
Boston, US
Employees
183↑ 15% increase
Entrada Therapeutics is a biopharmaceutical company focusing on intracellular biologics.
View company